共 50 条
Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in non-small cell lung cancer (NSCLC) patients with ECOG performance status 2.
被引:0
|作者:
Giner, V.
Juan Vidal, O.
Munoz, J., Sr.
Esquerdo, G.
Sanchez-Hernandez, A.
Gomez-Codina, J.
Aparisi, F.
Macia, S.
Lopez Jimenez, A.
Catot, S.
机构:
[1] Hosp Sagunto, Puerto Sangunto, Spain
[2] Hosp Arnau Vilanova, Valencia, Spain
[3] Hosp Doctor Peset, Valencia, Spain
[4] Hosp Clin Benidorm, Benidorm, Spain
[5] Hosp Prov Castellon, Castellon de La Plana, Spain
[6] Hosp La Fe, E-46009 Valencia, Spain
[7] Hosp Virgen de los Lirios, Alcoy, Spain
[8] Hosp Gen Elda, Elda, Spain
[9] Hosp Clin San Juan, Alicante, Spain
[10] Hosp Althaia Xarxa, Manresa, Spain
关键词:
D O I:
10.1200/jco.2010.28.15_suppl.e18083
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
e18083
引用
收藏
页数:2
相关论文